glp-1 clinics FDA Ruling on GLP-1s: How NP Clinic Owners Can Pivot, Thrive & Expand Their Practice Beyond Weight Loss How to Set Up a

These drugs were initially developed for type 2 diabetes treatment, and these medications have now received FDA approval for chronic weight management in individuals with obesity or overweight with weight-related health conditions

10.1038/s41574-021-00498-x Nat

Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): A multicentre, double-blind, randomised, placebo-controlled phase 2 study

[DOI] [PubMed] [Google Scholar] 10.Jung C.H., Jang J.E., Park J.-Y

Patients with missing demographic data (age or sex), type 1 DM, 30, missing baseline eGFR data, and those with a follow-up period 50%, and progression to ESKD with dialysis

Rotating injection sites helps reduce this risk